Okay, @gdombal I will concede that Boston is the center of the universe for biopharma/biotech (for now), though I maintain Minnesota still retains its dominance in all… Read more
Nsight Barbara Nelsen on the business of science.
In Part 1 of this series, we highlight what investors want to see in a company’s business plan and hear in the pitch in order… Read more
From seed stage through exit, convertible debt to reverse merger, funding strategies are critical for companies to secure the capital necessary for success. To help… Read more
Catching up on Minnesota news in the Star Tribune a few weeks ago, the following headline caught my eye: “Minnesota loses when tech firms head… Read more
I recently spoke with several corporate venture capital investors (CVCs) when I moderated a panel at the 2014 RESI Conference. The discussion gave definition about… Read more